1Cooke C,Nissen L,Sketris I,et al.Quantifying the use of the statin antilipemic drugs:comparisons and contrasts between Nova Scotia,Canada,and Queensland,Australia.Clin Ther,2005,27(4):497-508.
4Behan K,Cutts C,Tett SE.Uptake of new drugs in rural and urban areas of Queensland,Australia:the example of COX-2 inhibitors.Eur J Clin Pharmacol,2005,61(1):55-58.
5Montecucco F,Mach F.Update on statin-mediated anti-inflammatory activities in atherosclerosis.Semin Immunopathol,2009,31(1):127-142.
3He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation, 2004,110:405-411.
4Gardner CD, Winkleby MA, Fortmann SP. Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [ NHANES Ⅲ ] ,1988-1994) . Am J Cardiol, 2000, 86:299-304.
5Rodriguez C, Pablos-Mendez A, Palmas W, et al. Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians ≥65years of age living in New York City . Am J Cardiol, 2002,89:178-183.
6Heim DL, Holcomb CA, Loughin TM. Exercise mitigates the association of abdominal obesity with high-density lipoprotein cholesterol in premenopausal women: results from the third National Health and Nutrition Examination Survey.J Am Diet Assoc,2000,100:1347-1353.
7Shepherdd J, Cobbe S M, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hyperlipidaemia[J]. N Engl J Med, 1999,333(3):1301-1307.
8Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease:the scandinavian simvastatin survival study(4S)[J]. Lancet, 1994,344,1383-1389.
9Sacks F M, Pfeffer M A, Lemuel A M, et al. For the cholesterol and recurrent events trial investigators, the effect of pravastatin on coronary enents after myocardial infaxtion in patients with average cholesterol levels[J]. N Engl J Med, 1996,335:1001-1009.
10Jones P, Kafonek S, Laurora I, et al. For the CURVES investigators comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia(the curves study)[J]. Am J Cardiol, 1998,81(5):582-587.
